CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 28 filers reported holding CLOVIS ONCOLOGY INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $1,211,000 | +419.7% | 1,423,000 | +469.2% | 0.08% | +710.0% |
| Q3 2018 | $233,000 | -98.2% | 250,000 | -97.9% | 0.01% | -98.3% |
| Q2 2018 | $12,653,000 | +107.0% | 11,752,000 | +123.8% | 0.59% | +94.7% |
| Q1 2018 | $6,112,000 | -27.5% | 5,251,000 | -16.0% | 0.30% | -26.7% |
| Q4 2017 | $8,433,000 | +4.0% | 6,251,000 | +19.0% | 0.42% | +4.8% |
| Q3 2017 | $8,112,000 | -56.3% | 5,251,000 | -52.0% | 0.40% | -56.0% |
| Q2 2017 | $18,558,000 | -7.0% | 10,950,000 | -29.1% | 0.90% | -24.6% |
| Q1 2017 | $19,951,000 | +269.3% | 15,450,000 | +194.3% | 1.20% | +305.1% |
| Q4 2016 | $5,402,000 | +214.6% | 5,250,000 | +162.5% | 0.30% | +189.2% |
| Q4 2015 | $1,717,000 | -93.1% | 2,000,000 | -86.7% | 0.10% | -93.1% |
| Q3 2015 | $24,988,000 | – | 15,000,000 | – | 1.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINDEN ADVISORS LP | 70,125,000 | $118,981,000 | 5.01% |
| PFM Health Sciences, LP | 46,790,999 | $79,428,000 | 2.14% |
| Partner Investment Management, L.P. | 790,001 | $1,341,000 | 1.80% |
| Myriad Asset Management Ltd. | 10,000,000 | $16,984,000 | 1.18% |
| CSS LLC/IL | 10,950,000 | $18,558,000 | 0.90% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 9,074,000 | $15,403,000 | 0.42% |
| SSI INVESTMENT MANAGEMENT LLC | 2,784,000 | $4,715,000 | 0.42% |
| ZAZOVE ASSOCIATES LLC | 4,030,000 | $6,833,000 | 0.36% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 7,826,000 | $13,277,000 | 0.25% |
| LORD, ABBETT & CO. LLC | 18,243,000 | $30,967,000 | 0.09% |